AKORN INC (AKRX)
|
Consensus Forecast of AKORN INC Revenue in Millions  |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
11/07 |
| $52.90 |
$93.60 |
$75.89 |
$77.19 |
$85.55 |
12.8% |
|
Consensus Forecast of AKORN INC EPS  |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
| ($0.52) |
($0.08) |
($0.22) |
($0.09) |
($0.16) |
($0.05) |
$0.06 |
|
| AKRX (AKORN INC) |
$74.00 |
($11.10) |
-21.7% |
|
|
3.7 |
|
Industry Mean |
|
|
18% |
12% |
12.33 |
4.2 |
8.5 |
| S&P 500 |
|
|
23% |
11% |
13.71
| 1.9 |
|
|
|
|
|
|
|
|
|
CHME (CHINA MEDICINE) |
$65.00 |
$2.97 |
12.1% |
|
|
0.8 |
|
HITK (HI TECH PHARMA) |
$161.00 |
$29.73 |
26.4% |
10% |
10.86 |
1.7 |
19.7 |
CPD (CARACO PHARM) |
$234.00 |
($8.66) |
-16.8% |
|
65.75 |
0.8 |
7.5 |
CF is operating cash flow plus after-tax interest expense. |
|
| Discussion of Relative Valuation | | No comments yet. Be the first | |  |
|
|
|
| |
Created by: WikiMigrationBot.
Last Modification: Thursday 03 of June, 2010 05:38:52 CDT by WikiMigrationBot.